Summary
Work History
Education
Skills
Publications
Training
Accomplishments
Conference
MSc thesis project
Timeline
Generic
Roa'a Alnajjar

Roa'a Alnajjar

MSc Cancer Biology Graduate & Oncology Research Specialist Biomedical Scientist – Oncology Focus Molecular Oncology Researcher

Summary

A specialist in Medical Laboratory Sciences and Cancer Biology, with advanced expertise in laboratory analysis and disease diagnosis using modern molecular techniques. Experienced in scientific research, statistical analysis, and managing advanced laboratory equipment, with a strong commitment to quality standards and laboratory compliance. Highly skilled in interpreting laboratory results, preparing scientific reports, and effectively communicating in research and medical environments.

Work History

Trainee

King Hussein Cancer Center
04.2025 - Current
  • Learned new materials, processes, and programs quickly.
  • Attended training courses to build understanding of processes, techniques, and industry.
  • Participated in on-the-job training, working closely with supervisors and coworkers and asking appropriate questions.
  • Supported departmental tasks to increase understanding of industry processes.
  • Developed strong working relationships with trainees, fostering a supportive learning environment.
  • Promoted positive collaboration among trainees, encouraging teamwork and problem-solving skills.
  • Facilitated smoother operations by maintaining clean and organized workspace.
  • Engaged in problem-solving activities with peers to develop critical thinking skills, enhancing team resilience.
  • Participated in safety drills, ensuring readiness in case of workplace emergencies.
  • Observed packing operations to verify conformance to specifications.

Research Assistant

King Hussein Cancer Center
2025 - Current
  • Organized research materials, maintaining a well-ordered workspace conducive to productivity.
  • Participated actively in regular meetings with fellow researchers to discuss project updates, challenges faced, and lessons learned during ongoing activities.
  • Monitored project timelines, ensuring timely completion of tasks while maintaining high-quality output.
  • Conducted literature reviews to support hypothesis development and identify gaps in existing knowledge.
  • Contributed to the publication of research articles in peer-reviewed journals, showcasing expertise in various topics.
  • Collaborated with multidisciplinary teams to develop innovative research methodologies and strategies.
  • Managed laboratory equipment and resources, ensuring proper maintenance and optimal functionality.
  • Utilized statistical software for data analysis, generating accurate insights into complex datasets.
  • Enhanced research accuracy by meticulously organizing and analyzing data sets.
  • Analyzed results using analytical software and created reports.
  • Enhanced participant recruitment strategies, leading to more diverse and representative study samples.

Trainee

Itqan Pharmaceutical Ind.
01.2023 - 06.2023

Training

The Specialty Hospital
10.2022 - 01.2023

Pathology Section

Al-Bashir Hospital
03.2022 - 06.2022

Healthcare Instructor

Jordan Paramedic Society
01.2021 - 02.2022

Training Consultant

Freelance
01.2021 - 01.2022
  • In the field of health and capacity development

Covid 19 Vaccination Campaign

Jordanian Ministry of Health
04.2021 - 09.2021

Education

MSc - Cancer Biology

Kingston University
02.2025

Bachelor's degree - medical laboratory sciences

Al-Ahliyya Amman University
01.2023

Skills

Biological sample assessment

Publications

  • Albarki K, Khater B, Aldemerdash M, Shahin HN, Aldemerdash A, Saleh O, Alsafouti MN, Alnajjar R, Khaity A, Ammari O. IBCL-523: Comparative efficacy, safety, and cost-effectiveness of subcutaneous versus intravenous rituximab in Non-Hodgkin Lymphoma: A systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2024;24(Suppl 1):S501-S502. Presented at the 2024 SOHO Conference.
  • Albarki K, Khater B, Aldemerdash M, Shahin HN, Saleh O, Alnajjar R, Khaity A, Al-Hawi O. IBCL-506: Safety and efficacy of ibrutinomab tiuxetan versus rituximab in newly diagnosed and relapsed patients with Non-Hodgkin Lymphoma: A systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2024;24(Suppl 1):S499-S500. Presented at the 2024 SOHO Conference.

Training

  • TOT healthcare instructors’ course
  • Diploma in healthcare the international board of scientist’s human development
  • Infection control
  • Quality control
  • Health program & abilities development trainer
  • Basic life support
  • Medical injection and venipuncture
  • First aid course

Accomplishments

  • Successfully optimized an immunohistochemistry (IHC) protocol for antibody ICR10 to detect EGFR expression in renal cancer tissues, improving signal clarity and reproducibility.
  • Conducted quantitative and qualitative analysis of EGFR staining patterns, correlating expression levels with clinicopathological parameters for potential diagnostic and prognostic applications.
  • Applied molecular biology techniques (PCR, qPCR, Western blotting, ELISA) to assess gene and protein expression of cancer-related markers in solid tumor samples.
  • Utilized next-generation sequencing (NGS) data interpretation tools to identify actionable genetic alterations in solid tumors, with a focus on EGFR mutations and related signaling pathways.
  • Completed over 1,200 laboratory hours in advanced cancer biology experiments, covering both wet-lab molecular biology and data-driven biomarker analysis .
  • Presented research findings on EGFR as a therapeutic target at academic seminars, demonstrating strong scientific communication skills.
  • Conducted a comprehensive literature review on EGFR in renal cell carcinoma, synthesizing current global findings with local patient data.
  • Investigated multiple cancer biomarkers including HER2, KRAS, BRAF, TP53, and PIK3CA , evaluating their roles in tumor progression and therapeutic targeting.
  • Maintained adherence to Good Laboratory Practice (GLP) while handling sensitive biological samples for biomarker testing and validation.
  • Investigated the hallmarks of cancer including sustained proliferative signaling, evasion of growth suppressors, angiogenesis, and resistance to cell death.

Conference

• Participated in the 12th International Conference of the Jordanian Society of Hematology titled:

"Benign Hematological Disorders and Immunotherapy in Malignancies and Selected Tumors",

January 20-21, 2025, Amman – Jordan.

(Accredited with 6 CPD hours according to the Jordan Medical Council).

MSc thesis project

Immunohistochemical Optimization of Antibody ICR10 for Determining EGFR Expression in Kidney Cancer Patients.

Timeline

Trainee

King Hussein Cancer Center
04.2025 - Current

Trainee

Itqan Pharmaceutical Ind.
01.2023 - 06.2023

Training

The Specialty Hospital
10.2022 - 01.2023

Pathology Section

Al-Bashir Hospital
03.2022 - 06.2022

Covid 19 Vaccination Campaign

Jordanian Ministry of Health
04.2021 - 09.2021

Healthcare Instructor

Jordan Paramedic Society
01.2021 - 02.2022

Training Consultant

Freelance
01.2021 - 01.2022

Bachelor's degree - medical laboratory sciences

Al-Ahliyya Amman University

Research Assistant

King Hussein Cancer Center
2025 - Current

MSc - Cancer Biology

Kingston University
Roa'a AlnajjarMSc Cancer Biology Graduate & Oncology Research Specialist Biomedical Scientist – Oncology Focus Molecular Oncology Researcher